- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT07541352
A Hugo RAS Kolorektális Együttműködés (HRCC)
A Hugo RAS Colorectális Együttműködés (HRCC): Nemzetközi tanulmány a minimálisan invazív sebészet fejlesztésére
The Hugo RAS Colorectal Collaborative (HRCC) is an international, multicenter dataset of patients undergoing colorectal surgery using the Hugo RAS system. The registry aims to analyze short and long-term outcomes to provide real-world evidence on the safety and effectiveness of the system.
A tanulmány áttekintése
Állapot
Részletes leírás
This prospective observational study will gather data via standardized electronic Case Report Forms (eCRFs) across multiple international high-volume colorectal surgery centers. The study intends to foster the standardization of surgical techniques, evaluate the learning curve of surgeons, and identify surgical best practices for the Hugo RAS modular system. The total expected duration for the initial phase is approximately 3 years, followed by extended long-term follow-up.
Tanulmány típusa
Beiratkozás (Becsült)
Kapcsolatok és helyek
Tanulmányi kapcsolat
- Név: Matteo Rottoli, MD, PhD
- Telefonszám: +390516364823
- E-mail: matteo.rottoli@unibo.it
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Mintavételi módszer
Tanulmányi populáció
Adult patients (≥18 years) undergoing any type of elective or emergent colorectal surgery using the Hugo RAS system. The population will be drawn from participating high-volume colorectal surgery centers across multiple countries. All eligible patients at these centers will be enrolled to minimize selection bias.
Leírás
Inclusion Criteria:
- Adult patients (age ≥ 18 years)
- Scheduled to undergo any type of colorectal surgery (elective or emergent) where the Hugo RAS system is planned to be used
- Willing and able to provide written informed consent
Exclusion Criteria:
-Patients unable to provide informed consent
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Megfigyelési modellek: COHORT
- Időperspektívák: OTHER
Kohorszok és beavatkozások
Csoport / Kohorsz |
|---|
|
Patients undergoing Hugo RAS colorectal surgery
Adult patients (≥18 years) scheduled to undergo any type of elective or emergent colorectal surgery utilizing the Hugo™ RAS (Robotic-Assisted Surgery) System at participating high-volume colorectal surgery centers. The intervention of interest is the use of the Hugo RAS System, a medical device manufactured by Medtronic, which consists of a surgeon console, robotic arms with instrument manipulators, and a vision cart. The system is intended for performing minimally invasive colorectal surgical procedures. Because this is an observational study, patients will receive treatment according to the standard clinical practice of the participating centers. |
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Complications
Időkeret: Intraoperatively
|
Number of participants experiencing intraoperative complications, which will include the recording of robotic arm conflicts, system alarms (including red alarms), and any technical difficulties encountered. |
Intraoperatively
|
|
Rate of Postoperative Complications
Időkeret: Postoperatively (30-day and 90-day)
|
Number and severity of postoperative complications assessed using the Clavien-Dindo classification system |
Postoperatively (30-day and 90-day)
|
|
Operative Time
Időkeret: Intraoperatively
|
Total duration in minutes of the surgical procedure measured to evaluate the efficacy of the Hugo RAS system. |
Intraoperatively
|
|
Blood loss
Időkeret: Intraoperatively.
|
Measurement of blood loss during the surgical procedure. (ml) |
Intraoperatively.
|
|
Conversion Rate
Időkeret: Intraoperatively.
|
Measurement of conversion rates to open or traditional laparoscopic surgery (%) |
Intraoperatively.
|
|
Length of Hospital Stay
Időkeret: At discharge, assessed up to 90 days post-surgery
|
Total length (days) of patient hospital stay post-surgery. |
At discharge, assessed up to 90 days post-surgery
|
|
Hospital Readmission Rate
Időkeret: Up to 90 days post-surgery
|
Rate of hospital readmissions following discharge. |
Up to 90 days post-surgery
|
|
Pathological Outcomes: Margin Status and Lymph Node Yield
Időkeret: Up to 30 days post-surgery
|
Assessment of pathological outcomes, specifically evaluating margin status and lymph node yield. |
Up to 30 days post-surgery
|
|
Disease Recurrence Rate
Időkeret: Up to 5 years post-surgery
|
Monitoring of disease recurrence rates post-surgery. |
Up to 5 years post-surgery
|
|
Overall and Disease-Free Survival
Időkeret: Up to 5 years post-surgery
|
Collection of survival data, specifically overall survival and disease-free survival rates. |
Up to 5 years post-surgery
|
|
Long-term Functional Outcomes
Időkeret: Long-term follow-up (e.g., 1 year, 3 years post-surgery).
|
Assessment of long-term functional outcomes, such as bowel function. |
Long-term follow-up (e.g., 1 year, 3 years post-surgery).
|
|
Bowel Function Assessed by the LARS Score
Időkeret: Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
Bowel function will be evaluated using the unabbreviated Low Anterior Resection Syndrome (LARS) score questionnaire. The total score ranges from 0 to 42. A score of 0 to 20 indicates no LARS, 21 to 29 indicates minor LARS, and 30 to 42 indicates major LARS. Higher scores indicate worse bowel function and a worse outcome. |
Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
|
Fecal Incontinence Assessed by the Wexner Scale
Időkeret: Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
Fecal incontinence will be evaluated using the Cleveland Clinic (Wexner) Fecal Incontinence Score. The scale assesses the frequency of different types of incontinence and lifestyle alterations. The total score ranges from 0 to 20, where 0 represents perfect continence and 20 represents complete incontinence. Higher scores indicate more severe incontinence and a worse outcome. |
Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
|
Quality of Life Assessed by the EORTC QLQ-C30
Időkeret: Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
Quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). All scale and single-item measures are linearly transformed to a score ranging from 0 to 100. For the global health status and functional scales, a higher score represents a better level of functioning and a better quality of life. For the symptom scales and items, a higher score represents a higher level of symptomatology and a worse quality of life. |
Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
|
Health-Related Quality of Life Assessed by the EQ-5D-3L
Időkeret: Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
Health status will be evaluated using the EuroQol-5 Dimension-3 Level (EQ-5D-3L) questionnaire. This tool consists of a descriptive system and a Visual Analogue Scale (VAS). The descriptive system assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, which are converted into a single health utility index score (typically ranging from less than 0 to 1.0, where 1.0 represents full health). The EQ VAS records the patient's self-rated health on a vertical visual analogue scale ranging from 0 to 100. For both the index score and the VAS, higher scores indicate a better health status and a better outcome. |
Baseline, 6 months, 1 year, 2 years, and 3 years post-surgery
|
Együttműködők és nyomozók
Publikációk és hasznos linkek
Általános kiadványok
- Romero-Marcos JM, Sampson-Davila JG, Cuenca-Gomez C, Altet-Torne J, Gonzalez-Abos S, Ojeda-Jimenez I, Galaviz-Sosa ML, Delgado-Rivilla S. Colorectal procedures with the novel Hugo RAS system: training process and case series report from a non-robotic surgical team. Surg Endosc. 2024 Apr;38(4):2160-2168. doi: 10.1007/s00464-024-10760-8. Epub 2024 Mar 6.
- Rottoli M, Violante T, Calini G, Cardelli S, Novelli M, Poggioli G. A multi-docking strategy for robotic LAR and deep pelvic surgery with the Hugo RAS system: experience from a tertiary referral center. Int J Colorectal Dis. 2024 Oct 1;39(1):154. doi: 10.1007/s00384-024-04728-2.
- Cheng CL, Rezac C. The role of robotics in colorectal surgery. BMJ. 2018 Feb 12;360:j5304. doi: 10.1136/bmj.j5304.
- Irani JL, Hedrick TL, Miller TE, Lee L, Steinhagen E, Shogan BD, Goldberg JE, Feingold DL, Lightner AL, Paquette IM. Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons. Surg Endosc. 2023 Jan;37(1):5-30. doi: 10.1007/s00464-022-09758-x. Epub 2022 Dec 14.
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Becsült)
Elsődleges befejezés (Becsült)
A tanulmány befejezése (Becsült)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- HRCC
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
IPD terv leírása
Requests for access to anonymized individual patient-level data by external researchers will be considered on a case-by-case basis by the HRCC steering committee. A formal data sharing agreement outlining the terms of use, data security, and publication policies will be required. The primary aim is to protect patient confidentiality and ensure that data is used responsibly for advancing scientific knowledge in line with the registry's objectives.
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .